Antonio Roldão is the Head of Vaccine Development Laboratory at the Animal Cell Technology Unit (Health & Pharma Division, iBET). He graduated in Chemical Engineering at the Faculdade de Ciências e Tecnologia da Universidade Nova de Lisboa, and holds a PhD in Engineering and Technology Sciences, Systems Biology from ITQB-NOVA. His current research is driven by the aim to develop novel complex biologics with impact on Human and Animal Health. The basis for his work lies on the use and integration of multidisciplinary technologies such as synthetic biology, evolutionary and bioprocess engineering, and bottom-up systems biology to fasten the generation of the products.
He is an author of 20 scientific manuscripts in peer-reviewed journals and author/co-author of 3 book chapters. Writer of best PhD thesis of ITQB-NOVA in 2011, he is the Project Manager of Portuguese, Japanese and EU pharma/biotech funded projects and member of organizing committee of two international scientific meetings and five courses on animal cell technology and protein production. He is a reviewer in international scientific journals.